HemaSphere (Jun 2022)

P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.

  • J. Xavier-Ferrucio,
  • C. Luo,
  • G. Angelini,
  • S. Krishnamurthy,
  • N. Patel,
  • M. Pettiglio,
  • T. Collingsworth,
  • M. Isik,
  • A. Ghodssi,
  • A. Halfond,
  • J. Etchin,
  • Y. Keschner,
  • G. Mundelboim,
  • P. Tavares,
  • C. Cummins,
  • A. Falla,
  • D. Hazelbaker,
  • E. Paik,
  • J. Sanchez,
  • G. Ge,
  • J. Lydeard,
  • M. I. Lin,
  • T. Chakraborty

DOI
https://doi.org/10.1097/01.HS9.0000848572.60330.2f
Journal volume & issue
Vol. 6
pp. 1312 – 1313

Abstract

Read online

No abstracts available.